Role of haritakyadi varti anjana in the management of kaphaj abhishyanda

Randomised control clinical trial to evaluate the efficacy of haritakyadi varti anjana in kaphaj abhishyanda with special referance to acute mucopurulent conjunctivitis. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086523

Enrollment

Registered

2025-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients showing classical sign and symptoms of Kaphaj Netra Abhishyanda 2.Patients irrespective of sex, occupation and socio economic status will be selected

Exclusion criteria

Exclusion criteria: 1.Patients of age group below 16 years and above 50 years 2.Patients with other ocular diseases 3.Recently eye operated patients 4.Patients with other major systemic diseases 5.Using any other eye medication 6.Patients with sever complaints will exclude

Design outcomes

Primary

Measure	Time frame
To study the effect of Haritakyadi varti anjana in the management of Kaphaj Abhishyanda.Timepoint: 15 days	—

Secondary

Measure	Time frame
1.To study the detail literature about Kaphaj Abhishyanda 2.To study the detail literature about Acute Mucopurulent Conjunctivitis. 3.To study the effect of Haritakyadi Varti Anjan in Kaphaj Abhishyanda.Timepoint: 5 TO 15 Days	—

Countries

India

Contacts

Public ContactDipali Dilip Rupnar

LRP Ayurved Medical College and Hospital,Post Graduate Institute and Reasearch Centre,Islampur.

sunilwalvekar99@gmail.com9822442719

Outcome results